MLH1 and colonic neoplasm: These results were replicated and elaborated in colon tumor xenografts: tumors lacking MLH1 expression (through a genetic mutation) were not sensitized by decitabine, indicating that MLH1 hypermethylation can be a “driver‐like” event during chemoresistance development.31